Clinical response prediction and improvement for intravesical BCG treatment of superficial bladder cancer. BCG-INMUNO-RESP

View all the projects

Project - Active

Clinical response prediction and improvement for intravesical BCG treatment of superficial bladder cancer. BCG-INMUNO-RESP

2014-2017

Principal Investigators: Cecilia Cabrera

BCG intravesical instillations play a key role in treating superficial bladder cancer by reducing recurrence and limiting progression. Despite its proven effectiveness, however, a significant proportion of patients are non-responders and so exposed to an increased risk of recurrence and progression. Unfortunately, no early response marker is available as yet in clinical practice. The objective is to identify factors that predict response to bladder treatment with BCG.

  • Participant entities: IrsiCaixa AIDS Research Institute, Germans Trias i Pujol University Hospital, Fight AIDS Foundation
  • Funding entity: Filantropia

Subscribe to our newsletter

Back to Top
Irsi Caixa

Promoted by:

'La Caixa' Foundation Generalitat de Catalunya - Departament de Salut

 

HR Excellence in Research

Member of:

Cerca

In cooperation with: